R.Y. Lei

892 total citations
15 papers, 699 citations indexed

About

R.Y. Lei is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, R.Y. Lei has authored 15 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in R.Y. Lei's work include Breast Cancer Treatment Studies (7 papers), Global Cancer Incidence and Screening (3 papers) and Advanced Radiotherapy Techniques (3 papers). R.Y. Lei is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Global Cancer Incidence and Screening (3 papers) and Advanced Radiotherapy Techniques (3 papers). R.Y. Lei collaborates with scholars based in United States, China and Czechia. R.Y. Lei's co-authors include Elizabeth M. Jaffee, Anne M. Ercolini, R. Todd Reilly, Leisha A. Emens, Jean-Pascal Machiels, Francesca I. Okoye, Joshua T Vogelstein, Kathleen R. Cho, F. Xavier Bosch and Rong Wu and has published in prestigious journals such as PLoS ONE, International Journal of Radiation Oncology*Biology*Physics and Breast Cancer Research and Treatment.

In The Last Decade

R.Y. Lei

12 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.Y. Lei United States 7 425 349 227 148 92 15 699
C. Guha United States 4 135 0.3× 299 0.9× 231 1.0× 58 0.4× 60 0.7× 13 515
Wim Jongmans Netherlands 12 112 0.3× 273 0.8× 440 1.9× 94 0.6× 69 0.8× 18 615
Scott F. Winter United States 9 107 0.3× 121 0.3× 239 1.1× 52 0.4× 46 0.5× 10 413
Amparo Macías Cuba 7 184 0.4× 216 0.6× 231 1.0× 52 0.4× 176 1.9× 15 437
Sangeeta Kakoti Japan 7 262 0.6× 500 1.4× 243 1.1× 10 0.1× 42 0.5× 12 647
Leah Schmidt United States 4 336 0.8× 409 1.2× 268 1.2× 31 0.2× 18 0.2× 5 706
Pariya Sukhumalchandra United States 12 309 0.7× 304 0.9× 127 0.6× 31 0.2× 79 0.9× 22 483
Sue Sturrock Australia 6 308 0.7× 279 0.8× 161 0.7× 26 0.2× 49 0.5× 7 467
Annamaria De Filippo Italy 8 445 1.0× 395 1.1× 249 1.1× 29 0.2× 25 0.3× 9 685
Alexandro Landshammer Germany 6 229 0.5× 322 0.9× 122 0.5× 11 0.1× 42 0.5× 8 476

Countries citing papers authored by R.Y. Lei

Since Specialization
Citations

This map shows the geographic impact of R.Y. Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.Y. Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.Y. Lei more than expected).

Fields of papers citing papers by R.Y. Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.Y. Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.Y. Lei. The network helps show where R.Y. Lei may publish in the future.

Co-authorship network of co-authors of R.Y. Lei

This figure shows the co-authorship network connecting the top 25 collaborators of R.Y. Lei. A scholar is included among the top collaborators of R.Y. Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.Y. Lei. R.Y. Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cheng, Yongran, R.Y. Lei, Zijian Chen, et al.. (2025). Global burden of lung cancer attributable to occupational asbestos exposure: 1990 to 2021. Environmental Health. 24(1). 84–84.
2.
Hua, Lei, et al.. (2025). Burden of prostate cancer in China during 1990–2021 and the projections through 2050. Prostate International. 13(4). 219–226.
3.
Dong, Jingao, R.Y. Lei, Feiyang Ma, et al.. (2025). Machine learning-based prediction of distant metastasis risk in invasive ductal carcinoma of the breast. PLoS ONE. 20(2). e0310410–e0310410. 1 indexed citations
4.
6.
Lei, R.Y., et al.. (2015). Patterns of Surgical and Radiation Treatment for Early-Stage Breast Cancer in the State of Colorado. International Journal of Radiation Oncology*Biology*Physics. 93(3). E371–E371. 1 indexed citations
7.
Alvarado, Michael, Dennis L. Carter, J. Michael Guenther, et al.. (2015). The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12‐gene DCIS score™ result. Journal of Surgical Oncology. 111(8). 935–940. 30 indexed citations
8.
Lei, R.Y., Charles E. Leonard, Timothy K. Johnson, et al.. (2014). External Beam Accelerated Partial Breast Irradiation Yields Favorable Outcomes in Patients with Prior Breast Augmentation. Frontiers in Oncology. 4. 154–154. 9 indexed citations
9.
Lei, R.Y., et al.. (2013). Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Research and Treatment. 140(1). 119–133. 31 indexed citations
10.
Lei, R.Y., et al.. (2013). Disease Control Efficacy of Ductal Carcinoma In Situ (DCIS) Treated With Accelerated Partial Breast Irradiation (APBI). International Journal of Radiation Oncology*Biology*Physics. 87(2). S196–S196. 1 indexed citations
11.
Lei, R.Y., et al.. (2012). A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies With Oligometastases. International Journal of Radiation Oncology*Biology*Physics. 84(3). S632–S632. 1 indexed citations
12.
Lei, R.Y., et al.. (2011). Four-year Clinical Update from a Prospective Trial of Accelerated Partial Breast Intensity Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 81(2). S215–S215. 1 indexed citations
13.
Reilly, R. Todd, Jean-Pascal Machiels, Leisha A. Emens, et al.. (2001). The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.. PubMed. 61(3). 880–3. 122 indexed citations
14.
Machiels, Jean-Pascal, R. Todd Reilly, Leisha A. Emens, et al.. (2001). Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.. PubMed. 61(9). 3689–97. 364 indexed citations
15.
Greenspan, David L., Denise C. Connolly, Rong Wu, et al.. (1997). Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.. PubMed. 57(21). 4692–8. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026